AngioDynamics, Inc. Comprehensive Income
AngioDynamics, Inc. (ANGO) reported Comprehensive Income of -$27.04 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-14
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-05-31 was -$6.44M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-02-28 was -$6.38M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-11-30 was -$5.41M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-08-31 was -$8.82M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2026 was -$27.04M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$31.65M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$183.99M.
- AngioDynamics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$58.52M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-05-31 | -$6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$12.81M derived: sum of 2 quarters · filed 2026-07-14 | -$18.23M derived: sum of 3 quarters · filed 2026-07-14 | -$27.04M 10-K · filed 2026-07-14 |
| 2026-02-28 | -$6.38M 10-Q · filed 2026-04-02 | -$11.79M derived: sum of 2 quarters · filed 2026-04-02 | -$20.61M 10-Q · filed 2026-04-02 | -$25.15M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-11-30 | -$5.41M 10-Q · filed 2026-01-06 | -$14.23M 10-Q · filed 2026-01-06 | -$18.77M derived: sum of 3 quarters · filed 2026-07-14 | -$22.96M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-08-31 | -$8.82M 10-Q · filed 2025-10-02 | -$13.36M derived: sum of 2 quarters · filed 2026-07-14 | -$17.55M derived: sum of 3 quarters · filed 2026-07-14 | -$28.77M derived: sum of 4 quarters · filed 2026-07-14 |
| 2025-05-31 | -$4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$8.73M derived: sum of 2 quarters · filed 2026-07-14 | -$19.95M derived: sum of 3 quarters · filed 2026-07-14 | -$31.65M 10-K · filed 2026-07-14 |
| 2025-02-28 | -$4.19M 10-Q · filed 2026-04-02 | -$15.41M derived: sum of 2 quarters · filed 2026-04-02 | -$27.11M 10-Q · filed 2026-04-02 | -$42.12M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-11-30 | -$11.22M 10-Q · filed 2026-01-06 | -$22.92M 10-Q · filed 2026-01-06 | -$37.93M derived: sum of 3 quarters · filed 2026-07-14 | -$223.76M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-08-31 | -$11.70M 10-Q · filed 2025-10-02 | -$26.71M derived: sum of 2 quarters · filed 2026-07-14 | -$212.54M derived: sum of 3 quarters · filed 2026-07-14 | -$240.65M derived: sum of 4 quarters · filed 2026-07-14 |
| 2024-05-31 | -$15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$200.84M derived: sum of 2 quarters · filed 2026-07-14 | -$228.94M derived: sum of 3 quarters · filed 2026-07-14 | -$183.99M 10-K · filed 2026-07-14 |
| 2024-02-29 | -$185.83M 10-Q · filed 2025-04-02 | -$213.94M derived: sum of 2 quarters · filed 2025-04-02 | -$168.98M 10-Q · filed 2025-04-02 | -$191.32M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-11-30 | -$28.10M 10-Q · filed 2025-01-08 | $16.85M 10-Q · filed 2025-01-08 | -$5.49M derived: sum of 3 quarters · filed 2025-07-18 | -$18.54M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-08-31 | $44.95M 10-Q · filed 2024-10-03 | $22.61M derived: sum of 2 quarters · filed 2025-07-18 | $9.57M derived: sum of 3 quarters · filed 2025-07-18 | -$14.00K derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-05-31 | -$22.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | -$35.39M derived: sum of 2 quarters · filed 2025-07-18 | -$44.97M derived: sum of 3 quarters · filed 2025-07-18 | -$58.52M 10-K · filed 2025-07-18 |
| 2023-02-28 | -$13.05M 10-Q · filed 2024-04-09 | -$22.63M derived: sum of 2 quarters · filed 2024-04-09 | -$36.18M 10-Q · filed 2024-04-09 | -$44.62M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-11-30 | -$9.58M 10-Q · filed 2024-01-08 | -$23.14M 10-Q · filed 2024-01-08 | -$31.57M derived: sum of 3 quarters · filed 2024-07-25 | -$37.56M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-08-31 | -$13.55M 10-Q · filed 2023-10-05 | -$21.99M derived: sum of 2 quarters · filed 2024-07-25 | -$27.98M derived: sum of 3 quarters · filed 2024-07-25 | -$35.52M derived: sum of 4 quarters · filed 2024-07-25 |
| 2022-05-31 | -$8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | -$14.43M derived: sum of 2 quarters · filed 2024-07-25 | -$21.96M derived: sum of 3 quarters · filed 2024-07-25 | -$28.34M 10-K · filed 2024-07-25 |
| 2022-02-28 | -$5.99M 10-Q · filed 2023-03-31 | -$13.53M derived: sum of 2 quarters · filed 2023-03-31 | -$19.91M 10-Q · filed 2023-03-31 | -$38.17M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-11-30 | -$7.53M 10-Q · filed 2023-01-06 | -$13.91M 10-Q · filed 2023-01-06 | -$32.17M derived: sum of 3 quarters · filed 2023-08-03 | -$35.71M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-08-31 | -$6.38M 10-Q · filed 2022-10-11 | -$24.64M derived: sum of 2 quarters · filed 2023-08-03 | -$28.18M derived: sum of 3 quarters · filed 2023-08-03 | -$31.26M derived: sum of 4 quarters · filed 2023-08-03 |
| 2021-05-31 | -$18.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | -$21.79M derived: sum of 2 quarters · filed 2023-08-03 | -$24.88M derived: sum of 3 quarters · filed 2023-08-03 | -$27.05M 10-K · filed 2023-08-03 |
| 2021-02-28 | -$3.53M 10-Q · filed 2022-04-07 | -$6.62M derived: sum of 2 quarters · filed 2022-04-07 | -$8.79M 10-Q · filed 2022-04-07 | -$165.94M derived: sum of 4 quarters · filed 2022-07-22 |
| 2020-11-30 | -$3.09M 10-Q · filed 2022-01-07 | -$5.26M 10-Q · filed 2022-01-07 | -$162.41M derived: sum of 3 quarters · filed 2022-07-22 | -$168.11M derived: sum of 4 quarters · filed 2022-07-22 |
| 2020-08-31 | -$2.17M 10-Q · filed 2021-09-30 | -$159.32M derived: sum of 2 quarters · filed 2022-07-22 | -$165.02M derived: sum of 3 quarters · filed 2022-07-22 | -$167.52M derived: sum of 4 quarters · filed 2022-07-22 |
| 2020-05-31 | -$157.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | -$162.84M derived: sum of 2 quarters · filed 2022-07-22 | -$165.35M derived: sum of 3 quarters · filed 2022-07-22 | -$166.78M 10-K · filed 2022-07-22 |
| 2020-02-29 | -$5.70M 10-Q · filed 2021-03-31 | -$8.21M derived: sum of 2 quarters · filed 2021-03-31 | -$9.63M 10-Q · filed 2021-03-31 | $48.97M derived: sum of 4 quarters · filed 2021-07-27 |
| 2019-11-30 | -$2.50M 10-Q · filed 2021-01-08 | -$3.93M 10-Q · filed 2021-01-08 | $54.67M derived: sum of 3 quarters · filed 2021-07-27 | $55.64M derived: sum of 4 quarters · filed 2021-07-27 |
| 2019-08-31 | -$1.43M 10-Q · filed 2020-10-07 | $57.17M derived: sum of 2 quarters · filed 2021-07-27 | $58.14M derived: sum of 3 quarters · filed 2021-07-27 | $60.08M derived: sum of 4 quarters · filed 2021-07-27 |
| 2019-05-31 | $58.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $59.57M derived: sum of 2 quarters · filed 2021-07-27 | $61.50M derived: sum of 3 quarters · filed 2021-07-27 | $60.94M 10-K · filed 2021-07-27 |
| 2019-02-28 | $969.00K 10-Q · filed 2020-04-08 | $2.90M derived: sum of 2 quarters · filed 2020-04-08 | $2.34M 10-Q · filed 2020-04-08 | $4.13M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-11-30 | $1.93M 10-Q · filed 2020-01-08 | $1.37M 10-Q · filed 2020-01-08 | $3.16M derived: sum of 3 quarters · filed 2020-08-10 | $17.39M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-08-31 | -$561.00K 10-Q · filed 2019-10-04 | $1.23M derived: sum of 2 quarters · filed 2020-08-10 | $15.45M derived: sum of 3 quarters · filed 2020-08-10 | $15.90M derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-05-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $16.02M derived: sum of 2 quarters · filed 2020-08-10 | $16.46M derived: sum of 3 quarters · filed 2020-08-10 | $16.71M 10-K · filed 2020-08-10 |
| 2018-02-28 | $14.23M 10-Q · filed 2019-04-02 | $14.67M derived: sum of 2 quarters · filed 2019-04-02 | $14.92M 10-Q · filed 2019-04-02 | |
| 2017-11-30 | $444.00K 10-Q · filed 2019-01-07 | $692.00K 10-Q · filed 2019-01-07 | ||
| 2017-08-31 | $248.00K 10-Q · filed 2018-10-01 | |||
| 2017-02-28 | $2.84M 10-Q · filed 2018-04-05 | $16.01M derived: sum of 2 quarters · filed 2018-04-05 | $17.02M 10-Q · filed 2018-04-05 | |
| 2016-11-30 | $13.17M 10-Q · filed 2018-01-05 | $14.17M 10-Q · filed 2018-01-05 | ||
| 2016-08-31 | $1.00M 10-Q · filed 2017-09-29 | |||
| 2016-02-29 | $728.00K 10-Q · filed 2017-04-03 | $86.00K derived: sum of 2 quarters · filed 2017-04-03 | -$737.00K 10-Q · filed 2017-04-03 | |
| 2015-11-30 | -$642.00K 10-Q · filed 2017-01-06 | -$1.46M 10-Q · filed 2017-01-06 | ||
| 2015-08-31 | -$822.00K 10-Q · filed 2016-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |